May - 2016
| Previous Next | Showing Journal 3 of 10 |
Effect of Early Prophylactic High-Dose Recombinant Human Erythropoietin in Very Preterm Infants on Neurodevelopmental Outcome at 2 Years - A Randomized Clinical TrialG Natalucci, B Latal, B Kolle, et al JAMA, 2016, 315(19):2079-2085 This page is only available to Crit-IQ subscribers. To view the rest of this review and gain access to our vast array of critical care teaching tools including podcasts, vodcasts, modules, exam preparation tools, teaching aids and much more, login here, or Become a Member to register |
May |
Previous Comments
No Comments yet.
Comment
Critical care physicians have been interested in the neuroprotective functions of EPO for some time, with the recent negative adult EPO-TBI...